Literature DB >> 22954976

Safety and efficacy of mechanical thrombectomy with the Solitaire device in large artery occlusion.

Ji Eun Kim1, Ah-Ro Kim, Young Min Paek, Yong-Jin Cho, Byung-Hoon Lee, Keun-Sik Hong.   

Abstract

BACKGROUND AND
PURPOSE: Intravenous tissue plasminogen activator (TPA) has limited efficacy in proximal large vessel occlusions. This study was to assess the safety and efficacy of mechanical thrombectomy with a retrievable Solitaire stent in acute large artery occlusions .
MATERIALS AND METHODS: This is a single center study enrolling patients treated with Solitaire-assisted thrombectomy between November 2010 and March 2011. Inclusion criteria were severe stroke of National Institutes of Health Stroke Scale (NIHSS) score ≥10, treatment initiation within 6 hours from onset, and an angiographically verified occlusion of proximal middle cerebral artery (MCA) or internal carotid artery (ICA). The primary outcome was recanalization defined as Thrombolysis in Cerebral Infarct (TICI) reperfusion grade 2b/3. Secondary outcomes were good functional outcome at 3 months (modified Rankin Scale [mRS] ≤2), early substantial neurological improvement (NIHSS score improvement ≥8 at 24 hours), and symptomatic hemorrhagic transformation (SHT).
RESULTS: Ten patients were consecutively enrolled: Age: 72.4 ΁ 5.7 years; female: 70%; baseline median NIHSS score: 19.5; and ICA occlusion in 50% and M1 portion of MCA occlusion in 50%. Six patients received intravenous TPA before intra-arterial treatment, and five patients were treated with adjuvant intra-arterial urokinase. Successful recanalization was achieved in 7 (70%) patients. Four (40%) patients had a good functional outcome at 3 months, and three (30%) patients had an early substantial neurological improvement. SHT occurred in two patients (20%), and 3-month mortality rate was 30%. There was no procedure-related complication.
CONCLUSIONS: Mechanical thrombectomy with the Solitaire device can effectively recanalize proximal large vessel occlusions, and potentially improves clinical outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22954976     DOI: 10.4103/0028-3886.100701

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  3 in total

Review 1.  Retrievable stent thrombectomy in the treatment of acute ischemic stroke: analysis of a revolutionizing treatment technique.

Authors:  Brian P Walcott; Kevin M Boehm; Christopher J Stapleton; Brijesh P Mehta; Brian V Nahed; Christopher S Ogilvy
Journal:  J Clin Neurosci       Date:  2013-08-09       Impact factor: 1.961

2.  Efficacy and Safety of REVIVE SE Thrombectomy Device for Acute Ischemic Stroke: River JAPAN (Reperfuse Ischemic Vessels with Endovascular Recanalization Device in Japan).

Authors:  Nobuyuki Sakai; Shinzo Ota; Yasushi Matsumoto; Rei Kondo; Tetsu Satow; Michiya Kubo; Tomoyuki Tsumoto; Yukiko Enomoto; Taketo Kataoka; Hirotoshi Imamura; Kenichi Todo; Mikito Hayakawa; Hiroshi Yamagami; Kazunori Toyoda; Yasushi Ito; Kenji Sugiu; Yuji Matsumaru; Shinichi Yoshimura
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-03-09       Impact factor: 1.742

3.  "Missing clot" during mechanical thrombectomy in acute stroke using Solitaire stent retrieval system.

Authors:  Vikram Huded; Vivek Nambiar; Romnesh De Souza; Vikram Bohra; Ritesh Ramankutty
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.